Article
The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression.
Journal of psychiatric research - 1 Jun 2014
Okada Satoshi, Morinobu Shigeru, Fuchikami Manabu, Segawa Masahiro, Yokomaku Kana, Kataoka Tsutomu, Okamoto Yasumasa, Yamawaki Shigeto, Inoue Takeshi, Kusumi Ichiro, Koyama Tsukasa, Tsuchiyama Kounosuke, Terao Takeshi, Kokubo Yosuke, Mimura Masaru
Abstract excerpt
We examined the utility of DNA methylation profiles at the CpG island of SLC6A4 (DMS) as a diagnostic biomarker for major depression (MD). In addition, the relationship between DMS and the serotonin transporter gene-linked polymorphic region (5-HTTLPR) allele, the severity of symptoms, number of...
Topics
- Adult
- Antidepressive Agents
- Case-Control Studies
- CpG Islands
- DNA Methylation
- Depressive Disorder, Major
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Pharmacogenetics
- Psychiatric Status Rating Scales
